A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that ...
Researchers at the University of Alabama at Birmingham are working to better understand ALS and find new ways to slow or stop the disease.
Yentli Soto Albrecht has a rare genetic form of ALS and is working on research at Penn that could one day prove life-saving.
Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.
A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified ...
Experimental therapy RT1999 will soon be tested in the UK EXPERTS-ALS platform trial designed to rapidly screen potential ALS treatments.
A retinal image could help doctors quickly distinguish between similar neurodegenerative diseases, such as ALS and Alzheimer's disease, and with remarkable accuracy, according to new research ...
To our knowledge, this analysis is the largest EHR-based study for identifying drug repurposing candidates for ALS. We identified several drugs that warrant further assessment as therapeutic options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results